Shenghui Tang Selected Research

Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase)

1/2019

U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shenghui Tang Research Topics

Disease

19	Neoplasms (Cancer) 11/2022 - 03/2007
17	Breast Neoplasms (Breast Cancer) 10/2022 - 09/2013
15	Diarrhea 01/2022 - 12/2006
14	Fatigue 11/2022 - 01/2012
14	Nausea 11/2022 - 01/2012
13	Disease Progression 01/2021 - 08/2006
8	Vomiting 01/2022 - 06/2015
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2010
8	Neutropenia 01/2020 - 01/2012
7	Exanthema (Rash) 01/2022 - 01/2010
7	Hypertension (High Blood Pressure) 01/2022 - 12/2006
6	Headache (Headaches) 11/2022 - 10/2015
6	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 12/2006
6	Anemia 11/2022 - 10/2015
6	Alopecia (Baldness) 01/2022 - 09/2013
6	Constipation 01/2022 - 08/2017
5	Arthralgia (Joint Pain) 01/2022 - 10/2014
5	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2015
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2013
4	Dyspnea (Shortness of Breath) 01/2022 - 08/2017
4	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 09/2013
3	Cough 01/2022 - 10/2015
3	Asthenia 01/2022 - 01/2012
3	Abdominal Pain (Pain, Abdominal) 01/2022 - 10/2015
3	Infections 11/2021 - 08/2002
3	Triple Negative Breast Neoplasms 01/2021 - 07/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2013
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
3	Musculoskeletal Pain 01/2020 - 10/2015
3	Thrombocytopenia (Thrombopenia) 01/2020 - 12/2017
3	Dysgeusia (Parageusia) 12/2017 - 03/2007
2	Primitive Neuroectodermal Tumors (PNET) 11/2022 - 01/2012
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2022 - 01/2012
2	Hypoxia (Hypoxemia) 11/2022 - 08/2017
2	Myalgia 01/2022 - 10/2015
2	medullary Thyroid cancer 01/2021 - 07/2012
2	Leukopenia 01/2018 - 11/2015
2	Nasopharyngitis 01/2018 - 10/2015
2	Mucositis 01/2018 - 03/2007
2	Back Pain (Backache) 01/2018 - 10/2015
2	Melanoma (Melanoma, Malignant) 01/2016 - 10/2014
1	Dizziness (Lightheadedness) 11/2022
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 11/2022
1	Hemangioblastoma 11/2022
1	Fever (Fevers) 01/2022
1	Pain (Aches) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Spondylitis 11/2021
1	Discitis 11/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Ovarian Epithelial Carcinoma 01/2021

Drug/Important Bio-Agent (IBA)

11	PlatinumIBA 01/2021 - 01/2010
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
8	Hormones (Hormone)IBA 10/2022 - 07/2014
6	Trastuzumab (Herceptin)FDA Link 01/2021 - 09/2013
5	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2010
4	atezolizumabIBA 01/2020 - 01/2017
4	TabletsIBA 10/2014 - 01/2010
3	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 06/2015
3	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2017
3	Fulvestrant (Faslodex)FDA Link 11/2021 - 01/2020
3	Cyclin-Dependent Kinase 4IBA 11/2021 - 01/2018
3	Lipase (Acid Lipase)FDA Link 01/2021 - 12/2006
3	Alanine Transaminase (SGPT)IBA 01/2021 - 06/2015
3	Aromatase InhibitorsIBA 01/2020 - 01/2018
3	Docetaxel (Taxotere)FDA Link 11/2015 - 09/2013
2	CreatinineIBA 11/2022 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 12/2006
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2021
2	taxaneIBA 01/2021 - 01/2020
2	olaparibIBA 01/2021 - 10/2015
2	rucaparibIBA 01/2021 - 12/2017
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2018
2	Capecitabine (Xeloda)FDA Link 01/2021 - 09/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2018
2	Letrozole (Femara)FDA LinkGeneric 01/2020 - 11/2015
2	palbociclibIBA 01/2020 - 11/2015
2	Estrogen ReceptorsIBA 01/2020 - 11/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2017 - 06/2015
2	NivolumabIBA 01/2017 - 01/2016
2	Anaplastic Lymphoma KinaseIBA 11/2015 - 06/2015
2	pertuzumabIBA 11/2014 - 09/2013
2	Sunitinib (Sutent)FDA Link 01/2012 - 03/2007
1	belzutifanIBA 11/2022
1	abemaciclibIBA 10/2022
1	tivozanibIBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	capmatinibIBA 01/2022
1	margetuximabIBA 01/2022
1	Pain-FreeIBA 11/2021
1	PM 01183IBA 01/2021
1	trastuzumab deruxtecanIBA 01/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2021
1	IodineIBA 01/2021

Therapy/Procedure

26	Therapeutics 11/2022 - 01/2010
18	Drug Therapy (Chemotherapy) 01/2022 - 01/2010
4	Castration 01/2021 - 12/2013
2	Neoadjuvant Therapy 11/2014 - 07/2014
1	Radiotherapy 01/2022
1	Debridement 11/2021